ANGLE Plc Earnings Estimate
ANGLE Plc Earnings per Share Projection vs Actual
About ANGLE Plc Earnings Estimate
The earnings estimate module is a useful tool to check what professional financial analysts are assuming about the future of ANGLE Plc earnings. We show available consensus EPS estimates for the upcoming years and quarters. Investors can also examine how these consensus opinions have evolved historically. We show current ANGLE Plc estimates, future projections, as well as estimates 1, 2, and three years ago. Investors can search for a specific entity to conduct investment planning and build diversified portfolios. Please note, earnings estimates provided by Macroaxis are the average expectations of expert analysts that we track. If a given stock such as ANGLE Plc fails to match professional earnings estimates, it usually performs purely. Wall Street refers to that as a 'negative surprise.' If a company 'beats' future estimates, it's usually called an 'upside surprise.'
Please read more on our stock advisor page.ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products. The company was founded in 1994 and is based in Guildford, the United Kingdom. Angle Plc operates under Diagnostics Research classification in the United States and is traded on OTC Exchange. It employs 128 people.
Currently Active Assets on Macroaxis
Other Information on Investing in ANGLE OTC Stock
ANGLE Plc financial ratios help investors to determine whether ANGLE OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in ANGLE with respect to the benefits of owning ANGLE Plc security.